BeiGene launches $2bn share offering, backed by Amgen
Chinese biotech plans to raise the sum as working capital, as it looks to progress its pipeline.
Chinese biotech plans to raise the sum as working capital, as it looks to progress its pipeline.
Sanofi looks to supplement its Sarclisa therapy with investigational treatment to treat multiple myeloma.